Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03791398
Title BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (379)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Khaldoun Almhanna
Indications

colorectal cancer

Therapies

Nivolumab + ONC201

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals Recruiting Providence Rhode Island 02903 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field